Address
GIMV NV
37 Karel Oomstraat
2018 Antwerpen
Belgium
Phone
Website
Recent investment activity
KANDO id: 713
Corporate information
Also known as
Gewestelijke Investeringsmaatschappij voor Vlaanderen
Registration country
Funding rounds
Investment preferences
Focus countries
France
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 22 of 22| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | |||
|
|
Ceres Inc | Plant genomics biotechnology company | N/A | |||
|
|
ChemoCentryx Inc | N/A | ||||
|
|
Ebuzzing SA | Leading global platform for social video advertising. | N/A USD 14,500,000 (USD 14,500,000) | |||
|
|
Interwise Inc | N/A | ||||
|
|
Nereus Pharmaceuticals Inc | Series D | ||||
|
|
Nereus Pharmaceuticals Inc | N/A | ||||
|
|
Nereus Pharmaceuticals Inc | Series A | ||||
|
|
Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | N/A | |||
|
|
Plexxikon Inc | N/A | ||||
|
|
Proficient Systems Inc | Enterprise software company. | N/A | |||
|
|
Prosensa | N/A | ||||
|
|
Santhera Pharmaceuticals AG | Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006. | N/A | |||
|
|
Ubidyne Inc | Developer of an antenna embedded digital radio tech. | Series B | |||
|
|
Xanthus Pharmaceuticals Inc | N/A | ||||
|
|
CoreOptics GmbH | N/A | ||||
|
|
Coreoptics Inc | Venture | ||||
|
General Fusion Inc | General Fusion is developing fusion technology to generate affordable, safe and plentiful energy. | Series E | |||
|
GOVECS | Venture Led the round. | ||||
|
|
McPhy | Venture | ||||
|
PowerInbox Inc | E-mail based, personalized content recommendation platform that increases reader engagement while providing incremental revenue for e-mail publishers. | Series A Initial investment | |||
|
Seedcamp Investments LLP | Early stage mentoring and investment programme for European startups. | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Dirk Boogmans | [email protected] | |||
| Alex Brabers | [email protected] | |||
| Patrick Van Beneden | Vice President
Life Sciences |
[email protected] | ||
| Dirk Beeusaert | ||||
| Paul De Ridder | ||||
| Geert-Jan van Logtestijn | ||||
| Marc Vercruysse |